Companies: 10,795·Total market cap: $144.5T
Nasus Pharma Ltd.

Nasus Pharma Ltd.

NSRXAMEXHealthcare● Active
$3.00
+$0.09(+3.09%)
Market Cap$25837857
P/E Ratio
52W High$9.99
52W Low$1.98
Overview

Nasus Pharma Ltd.(NSRX)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · NSRX · 截至 Jun 9, 2026

关键指标

EPS (TTM)nsrx eps ttm · nsrx earnings per shareEarnings history
PE Ratio (TTM)nsrx pe ratio ttm · nsrx price to earningsPE Ratio deep dive
Revenue (TTM)nsrx revenue ttm · nsrx annual revenueFull revenue history
Dividend Yield不分红does nsrx pay dividends · nsrx dividend yieldDividend history
Shares Outstanding9.1Mnsrx shares outstanding · nsrx floatShares outstanding history
Next EarningsTBAnsrx earnings date · nsrx next earningsEarnings history

财务快照

完整财报
FY 2024Revenue$0.00
202220232024
nasus pharma ltd. revenue · nsrx revenue 2024
FY 2024Net Income-$1.5M▼ 45.77% YoY
202220232024
nasus pharma ltd. net income · nsrx profit 2024
FY 2024EPS$-0.17▼ 41.67% YoY
202220232024
nsrx eps · nasus pharma ltd. earnings per share 2024

分析师评级与目标价

完整预测
SellBuy
Buy1 位分析师is nsrx a buy · nsrx analyst rating
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$22.00Low
$3.00Current
$22.00Avg Target上涨空间 633.36%
$22.00High
nsrx price target · nsrx 12 month forecast

合计: 1 · 买入占比: 100.0%

根据过去 3 个月内 1 位华尔街分析师,NSRX 共识评级为 Buy,12 个月平均目标价 $22.00 (较现价 $3.00 上涨空间 633.36%)

股票表现

完整历史
1D+3.09%
1W-4.77%
1M-4.77%
3M-27.01%
YTD-67.21%
1Y-63.64%
5Y-63.64%

关于 Nasus Pharma Ltd.

CEODan Teleman
IPO DateAug 13, 2025
Employees2
CountryIL

Nasus Pharma Ltd. is a specialized pharmaceutical firm currently advancing through clinical trials. Their primary focus is on developing innovative nasal medications designed to swiftly address critic…

what is nasus pharma ltd. · nsrx stock overview · nasus pharma ltd. company profile · who is nasus pharma ltd. ceo · nsrx AMEX · nasus pharma ltd. headquarters · nasus pharma ltd. business segments

关于股票概览与关键数据

Nasus Pharma Ltd.(NSRX)是 Biotechnology 行业的 Healthcare 类公司,于 Aug 13, 2025 在 AMEX 上市。截至最近交易日,NSRX 股价为 $3.00,市值约为 $25.8M。过去12个月累计回报 -63.64%,年初至今回报 -67.21%。

根据 1 位华尔街分析师,Nasus Pharma Ltd. 股票共识评级为Buy,12个月平均目标价为 $22.00。2024 财年 Nasus Pharma Ltd. 营收 —,净利润 -$1.5M。更多数据(营收历史、盈利、股息、市盈率)请使用上方标签页。

常见问题

截至最近一个交易日,Nasus Pharma Ltd.(NSRX)股价为 $3.00,在 AMEX 上市,52周区间为 $1.98 – $9.99。

NSRX 最新股价NSRX quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 9, 2026本内容不构成投资建议